These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16476835)

  • 1. Alternating chemotherapy and radiotherapy in locally advanced head and neck cancer: an alternative?
    Merlano M
    Oncologist; 2006 Feb; 11(2):146-51. PubMed ID: 16476835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Head and neck cancer].
    Inuyama Y; Fukuda S; Fujii M
    Gan To Kagaku Ryoho; 1995 May; 22(6):732-8. PubMed ID: 7755381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future chemotherapy and radiotherapy options in head and neck cancer.
    Merlano M; Mattiot VP
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):395-403. PubMed ID: 16503856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current status of clinical trials on pre- and postoperative chemotherapy for head and neck cancer].
    Inuyama Y; Fukuda S; Horiuchi M
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():338-47. PubMed ID: 7986113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma.
    Rosenthal DI; Ang KK
    Semin Radiat Oncol; 2004 Apr; 14(2):153-66. PubMed ID: 15095261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
    Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
    Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
    Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
    BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for locally advanced head and neck cancer - Phase II study.
    Fuwa N; Kodaira T; Furutani K; Tachibana H; Nakamura T; Daimon T
    Oral Oncol; 2007 Nov; 43(10):1014-20. PubMed ID: 17258494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas.
    Medina JA; Rueda A; de Pasos AS; Contreras J; Cobo M; Moreno P; Benavides M; Villanueva A; Alba E
    Radiother Oncol; 2006 Apr; 79(1):34-8. PubMed ID: 16626826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative clinical studies for head and neck cancer in Japan].
    Fujii M
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1502-8. PubMed ID: 12355935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent chemotherapy and radiotherapy for head and neck cancer.
    Burri RJ; Lee NY
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):293-302. PubMed ID: 19275508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer.
    Vokes EE; Haraf DJ; Kies MS
    Semin Oncol; 2000 Aug; 27(4 Suppl 8):34-8. PubMed ID: 10952436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer.
    Cho YH; Lee SH; Kim DW; Wu HG; Hah JH; Rhee CS; Sung MW; Kim KH; Heo DS
    Head Neck; 2008 Mar; 30(3):346-50. PubMed ID: 17972310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of head and neck cancer: radiation therapy].
    Chatani M; Yoshino K
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):271-6. PubMed ID: 8712818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forecasting the performance status of head and neck cancer patient treatment by an interval arithmetic pruned perceptron.
    Drago GP; Setti E; Licitra L; Liberati D
    IEEE Trans Biomed Eng; 2002 Aug; 49(8):782-7. PubMed ID: 12148816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant treatment of head and neck cancers: advances and challenges].
    Bernier J
    Bull Cancer; 2007 Sep; 94(9):823-7. PubMed ID: 17878103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
    Milano MT; Vokes EE; Kao J; Jackson W; List MA; Stenson KM; Witt ME; Dekker A; MacCracken E; Garofalo MC; Chmura SJ; Weichselbaum RR; Haraf DJ
    Int J Oncol; 2006 May; 28(5):1141-51. PubMed ID: 16596230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RADPLAT: an alternative to surgery?
    Alkureishi LW; de Bree R; Ross GL
    Oncologist; 2006 May; 11(5):469-80. PubMed ID: 16720847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.